All News

In 2018, The American Journal of Managed Care® team traveled all over the country to provide conference coverage for some of the biggest meetings in the industry. Here are the top 5 most-read conference pieces from this year.

A joint assessment comparing the results of value frameworks created by the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO) found that the frameworks produce comparable measures of the clinical benefits of new cancer therapies in roughly two-thirds of more than 100 drug comparisons examined.

Two of The American Journal of Managed Care®'s top 5 most-read news stories were themselves top-5 roundups of hot topics in healthcare this year. The list was rounded out by cardiovascular, diabetes, and cancer news.

Reuters examined internal J&J documents as well as court records and said they show that, from at least 1971 to the early 2000s, the company’s raw talc and finished powders sometimes tested positive for small amounts of asbestos, while the company denies the claim; Larry Merlo, chief executive officer of CVS Health, said he expects 15% to 20% of the drugstores to include an in-store medical clinic; HHS' internal watchdog will investigate the death of a 7-year-old Guatemalan girl after she was detained by US border agents.

Practices participating in the Oncology Care Model have now received performance results for 2 periods, and many practices were surprised that they didn’t perform as well as expected. In general, some of the practices have found it difficult to predict success in the model, but there have been positive results from the OCM.

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease, and patients can differ markedly in their rate of lung function decline and frequency of exacerbations. A recent study sought to determine what proportion of between-individual variability in symptoms can be explained by lung function versus all other observable characteristics.

A federal judge in Texas ruled that the Affordable Care Act's individual coverage mandate is unconstitutional and that the rest of the law must also fall, likely setting up a fight in the Supreme Court and throwing into question the idea that consumers should have protection against discrimination by insurers for having pre-existing health conditions.

CMS recently released the Oncology Care Model (OCM) performance period 1 (PP1) true-up 1 and the performance period 2 (PP2) initial reconciliation. The performance data show some practices may be gaining traction with their success, while others have found it difficult to make progress as CMS continues to refine the payment methodology for the model across performance periods.

A recent report, published by the Annals of the American Thoracic Society, assessed trends in chronic obstructive pulmonary disease (COPD) hospitalizations and in-hospital deaths in the United States and found that the number of in-hospital deaths for COPD has decreased; however, women account for a higher proportion of the hospitalizations and in-hospital deaths.

The 9th US Circuit Court of Appeals narrowed a Trump administration order that had sought to enforce new rules that undermine an Affordable Care Act requirement for employers to provide insurance that covers women's birth control based on moral or religious grounds; House Democrats are planning to vote next year on legislation to fund research on gun injuries and deaths, reframing the issue as a public health concern; despite California being cited as a rigorous example in doctor oversight, very few sexual misconduct complaints are reported to the state medical board.

As 2018 draws to a close, the articles in the December issue of The American Journal of Managed Care® (AJMC®) touch on some of the timeliest topics of the year, including the value of innovative immuno-oncology treatments, results of practice transformation initiatives, and much more. Here are 5 findings from the research published in the issue.

This week, the top managed care news included a report that found uninsured rates were on the rise in 2017; an analysis of rising health insurance costs for families; predictions for cardiology trends in 2019.

The CDC reported the number of drug overdose deaths per year increased 54% from 2011 to 2016, with the synthetic drug fentanyl involved in most overdoses in 2016, although actual numbers of all overdose deaths may be underreported. The report also showed how multiple drugs are typically involved in overdose deaths.